Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Industry Valued at $18.54 Billion by 2029 With CAGR of 27.8% | Size and Share Insights
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market From 2025 To 2029?
The market size of contract development and manufacturing organizations (CDMO) for cell and gene therapy has witnessed significant expansion in the past few years. The market is forecasted to escalate from $5.41 billion in 2024 to $6.94 billion in 2025, indicating a compound annual growth rate (CAGR) of 28.2%. This surge during the historical period is largely owed to advancements in technology, supportive regulatory environment, amplified funding, a high incidence of genetic disorders, and the growth in strategic collaborations.
What Is the Projected Market Size of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
The market for contract development and manufacturing organizations (CDMO) in the cell and gene therapy sector is projected to undergo significant expansion in the coming years. Its value is forecasted to reach $18.54 billion by 2029, with a compound annual growth rate (CAGR) of 27.8%. Contributing factors to this projected growth during the forecast period include a broadening of therapeutic applications, changing regulatory landscapes, boosting investments, technological advancements, and global partnerships. The forecast period is also likely to see trends such as a growing demand for personalized treatment options, an increase in automation and digitalization, manufacturing capacity expansions, the rise of innovative delivery systems, and an enhanced focus on environmental sustainability.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15753&type=smp
Who are the Major Competitors in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Outlook?
Major companies operating in the cell and gene therapy contract development and manufacturing organization (CDMO) market are Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Ajinomoto Co Inc., Lonza Group, Catalent Inc., Charles River Laboratories International Inc., Sartorius Stedim Biotech, Samsung Biologics Co Ltd., WuXi Biologics, Recipharm AB, Almac Group Ltd., KBI Biopharma, Rentschler Biopharma, Bio Elpida, Oxford BioMedica Plc, Avid Bioservices Inc., Cell and Gene Therapy Catapult, VGXI Inc., Genezen Laboratories Inc., Pluri Inc., OmniaBio Inc.
What Is Fueling Growth in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
The escalating incidence of cancer is expected to drive the expansion of the cell and gene therapy contract development and manufacturing organization (CDMO) market in the future. Cancer, a group of diseases marked by the uncontrolled proliferation and dispersion of abnormal cells in the body, has been increasingly prevalent because of aging demographics, lifestyle modifications, environmental triggers, and better diagnostic methods. Cell and gene therapy contract development and manufacturing organization (CDMO) plays a crucial role in decreasing the incidence of cancer by creating and producing innovative, targeted therapies that improve efficacy and patient outcomes. For instance, in October 2022, Macmillan Cancer Support, a UK-based charity, projected that the population of individuals living with cancer in the UK is set to rise from 3 million in 2022 to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Hence, the escalating incidence of cancer fuels the expansion of the cell and gene therapy contract development and manufacturing organization (CDMO) market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15753&type=smp
Which Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Segments Are Growing the Fastest?
The cell and gene therapy contract development and manufacturing organization (CDMO) market covered in this report is segmented –
1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy
2) By Phase: Phase 1, Phase 2, Phase 3, Phase 4
3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, Plasmid DNA-Based Gene Therapy
2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy, TCR-T Cell Therapy, NK Cell Therapy
3) By Cell Therapy: Stem Cell Therapy, Progenitor Cell Therapy, Immune Cell Therapy
Which Industry Trends Are Shaping the Future of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
Leading corporations in the cell and gene therapy contract development and manufacturing organization (CDMO) market are making concerted efforts to broaden their offerings with technological advancements like PluriMatrix. This is with the aim of boosting scalability, productivity, and the standard of cell-based goods production. The PluriMatrix system is specifically designed for high-volume production of cell-based items. Ensuring high yield and uniform quality, this technology enhances the 3D expansion of cells on a commercial scale through a validated, automated, and fully controlled process. For example, in January 2024, Pluri, a biotech company based in Israel, introduced PluriCDMO, a fresh business unit offering cell therapy manufacturing services under the CDMO model. The new unit encompasses a 47,000-square-foot facility for good manufacturing practice (GMP) cell therapy production. Pluri’s new division delivers comprehensive services, from early preclinical stages to late-stage clinical trials and eventual commercialization. This encompasses process and analytical development, scale-up, validation, logistics, automation, and regulatory-approved comparability studies, as elucidated in an official company announcement. With its advanced PluriMatrix technology, the company is able to provide sophisticated cell therapy manufacturing services.
Access The Full Report Here:
Which Countries Are Leading the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15753
This Report Delivers Insight On:
1. How big is the cell and gene therapy contract development and manufacturing organization (cdmo) market, and how is it changing globally?
2. Who are the major companies in the cell and gene therapy contract development and manufacturing organization (cdmo) market, and how are they performing?
3. What are the key opportunities and risks in the cell and gene therapy contract development and manufacturing organization (cdmo) market right now?
4. Which products or customer segments are growing the most in the cell and gene therapy contract development and manufacturing organization (cdmo) market?
5. What factors are helping or slowing down the growth of the cell and gene therapy contract development and manufacturing organization (cdmo) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
